Manufacturer cost-sharing assistance programs can save chronically ill patients hundreds to thousands of dollars annually

A recentanalysis by IQVIA shows that chronically ill patients who used manufacturer cost-sharing assistance in 2019 saved hundreds to thousands of dollars on their out-of-pocket costs. IQVIA found that nearly one-third of commercially insured patients taking brand anticoagulants, diabetes or oncology medicines used manufacturer assistance to help pay their cost sharing for one or more prescriptions, along with more than half of patients taking brand HIV medicines and 70% of patients taking brand multiple sclerosis medicines. For many patients facing high out-of-pocket cost burdens, manufacturer cost-sharing assistance programs are an important source of financial support which can help to improve patient adherence and lead to improved patient outcomes.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Drug Cost Patient Assistance Programs Out-of-Pocket Costs Medicaid Let's Talk About Cost Source Type: news